Treatment of patients with arterial hypertension and other stroke risk factors in clinical practice. the prognos program

Terapevticheskii Arkhiv

Volumn 81, Issue 9, 2009, Pages 19-23

  Bubnova, M G ^a   Oganov, R G ^a  

^a NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

Author keywords

Antihypertensive therapy; Arterial hypertension; Cerebral stroke; Hyzaar

Indexed keywords

HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LOSARTAN;

AGED; ARTICLE; BLOOD; DRUG COMBINATION; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTOR; STROKE;

AGED; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 70350717861     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Collins R., Mc Mahon S. Blood pressure, antihypertensive drug treatment and risks of stroke and of coronary heart disease. Br. Med. Bull. 1994; 50: 272-298. (Pubitemid 24165020)
2. Keli S., Bloemberg B., Kromhoul D. Predictive value of repeated systolic blood pressure measurements for stroke risk: The Zut-phen Study. Stroke 1992; 23: 347-351.
3. Sacco R. L., Benjamin H. L., Broderick I. P. et al. American Heart Association prevention conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997: 28: 1507-1517.
4. Mohr J. P., Albers G. W., Amarenco P. et al. American Heart Association prevention conference. IV. Prevention and rehabilitation of stroke. Etiology of Stroke. Stroke 1997:28: 1501-1506.
5. Brown R. D., Whisnant J. P., Sicks R. D. et al. Stroke incidence, prevalence, and survival: Secular trends in Rochester, Minnesota, through 1989. Stroke 1996; 27: 373-380. (Pubitemid 26081427)
6. McMahon S., Rodgers A. The epidemiologic association between blood pressure and stroke: Implication for primary and secondary prevention. Hypertens. Res. 1994; 17 (suppl. 1): S23-S32. (Pubitemid 24195223)
7. Materson B. L., Reda D. L., Cushman W. C. et al. Single-drug therapy for hypertension in men. A comparison of six antihy-pertension agents with placebo. N. Engl. J. Med. 1993; 328: 914-921. (Pubitemid 23086643)
8. Dahlof B., Devereux R. B., Kjeldsen S. E. et al. Cardiovascular morbidity and mortality in the Losartan Intervention For End-point reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995-1003. (Pubitemid 34286536)
9. Devgun M., Dhillon H. Importance of diural variations on clinical value and interpretation of serum urate measurements. J. Clin. Pathol. 1992; 45: 110-113.
10. Soffer B., Wright J. et al. Effect of losartan on a background of hydrochlorothiazide in patients with hypertension. Hypertension 1995; 26: 112-117.